Shortage reports
Actual shortage:
31 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
6 (1%)
Resolved:
431 (92%)
468
Discontinuation Reports
To be discontinued:
0 (0%)
Discontinued:
41 (100%)
Reversed:
0 (0%)
41
293 (58%)
0 (0%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TARO-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2025-02-10 | 2025-06-10 | 250013 |
| TARO-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2025-10-06 | 2025-11-03 | 268756 |
| TARO-EZETIMIBE | 10MG | TABLET | Resolved | 2024-11-11 | 2025-01-28 | 242610 |
| TARO-EZETIMIBE | 10MG | TABLET | Resolved | 2025-03-17 | 2025-06-04 | 252806 |
| TARO-EZETIMIBE | 10MG | TABLET | Resolved | 2025-07-18 | 2025-09-02 | 263188 |
| TARO-EZETIMIBE | 10MG | TABLET | Resolved | 2025-10-06 | 2025-10-14 | 268762 |
| TARO-FENOFIBRATE E | 145MG | TABLET | Resolved | 2024-09-11 | 2025-02-03 | 237296 |
| TARO-GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-05 | 2025-05-20 | 215021 |
| TARO-GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2025-10-06 | 2025-11-11 | 268765 |
| TARO-GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-12-03 | 2021-05-01 | 129474 |
| TARO-GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2022-09-16 | 2025-12-05 | 169507 |
| TARO-GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-01-31 | 2021-05-01 | 132988 |
| TARO-IMIPENEM-CILASTATIN | 500MG 500MG | POWDER FOR SOLUTION | Resolved | 2021-05-01 | 2021-06-16 | 138546 |
| TARO-IRBESARTAN | 75MG | TABLET | Resolved | 2021-05-01 | 2021-07-13 | 138509 |
| TARO-IRBESARTAN | 75MG | TABLET | Resolved | 2025-01-29 | 2025-09-02 | 248999 |
| TARO-IRBESARTAN | 150MG | TABLET | Resolved | 2025-01-29 | 2025-10-06 | 249002 |
| TARO-IRBESARTAN | 300MG | TABLET | Resolved | 2025-01-29 | 2025-09-02 | 249005 |
| TARO-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Resolved | 2025-10-06 | 2025-12-05 | 268771 |
| TARO-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-01-05 | 2024-02-08 | 215033 |
| TARO-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Resolved | 2022-11-03 | 2023-02-10 | 173640 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RAN-AMLODIPINE | 5MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115038 |
| RAN-AMLODIPINE | 10MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115052 |
| RAN-AMLODIPINE | 5MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115046 |
| RAN-AMLODIPINE | 10MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115049 |
| RAN-CLARITHROMYCIN | 500MG | TABLET | Discontinued | 2020-02-02 | 2020-02-02 | 105091 |
| RAN-CLARITHROMYCIN | 250MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115059 |
| RAN-DONEPEZIL | 5MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80060 |
| RAN-DONEPEZIL | 10MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80063 |
| RAN-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-08-09 | 2019-08-10 | 91266 |
| RAN-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-08-09 | 2019-08-10 | 91269 |
| RAN-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-08-09 | 2019-08-10 | 91261 |
| RAN-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80025 |
| RAN-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80028 |
| RAN-LISINOPRIL | 20MG | TABLET | Discontinued | 2021-12-07 | 2021-12-07 | 150674 |
| RAN-LISINOPRIL | 10MG | TABLET | Discontinued | 2020-05-27 | 2020-05-27 | 115806 |
| RAN-LISINOPRIL | 5MG | TABLET | Discontinued | 2021-12-07 | 2021-12-07 | 150671 |
| RAN-LISINOPRIL | 5MG | TABLET | Discontinued | 2020-05-27 | 2020-05-27 | 115803 |
| RAN-PANTOPRAZOLE | Discontinued | 2019-03-29 | 2019-03-29 | 80057 | ||
| RAN-PREGABALIN | 225MG | CAPSULE | Discontinued | 2019-10-04 | 2019-10-04 | 95487 |
| RAN-PREGABALIN | 300MG | CAPSULE | Discontinued | 2020-05-27 | 2020-05-27 | 115811 |